温氏股份(300498.SZ):擬向多家合作銀行申請總額不超600億元綜合授信
格隆匯8月18日丨温氏股份(300498.SZ)公佈,公司第三屆董事會第三十七次會議審議通過了《關於向銀行申請授信融資額度的議案》。
公司(含全資子公司及控股子公司)擬向中國進出口銀行等多家合作的銀行申請總額不超過人民幣600億元的綜合授信,在額度範圍內可循環使用,最終以各家銀行實際審批的授信額度為準。
上述授信總額不等於公司實際融資金額,實際融資金額以在授信額度內各家銀行與公司(全資子公司及控股子公司)實際發生的融資金額為準。在授信總額範圍內,公司授權人士可根據公司實際資金需求調整各銀行間的授信額度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.